Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy. [electronic resource]
Producer: 20110111Description: 1437-44 p. digitalISSN:- 1433-7339
- Activities of Daily Living
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antiemetics -- administration & dosage
- Antineoplastic Agents -- adverse effects
- Dexamethasone -- therapeutic use
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Male
- Middle Aged
- Nausea -- chemically induced
- Neoplasms -- drug therapy
- Ondansetron -- therapeutic use
- Piperazines -- administration & dosage
- Piperidines -- administration & dosage
- Quality of Life
- Surveys and Questionnaires
- Vomiting -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.